Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. - Wikidata - wikimedia - TriplyDB

Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth.

Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth.

http://www.wikidata.org/entity/Q40652271

about

Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension PPARs and the cardiovascular system The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension Pathobiology of pulmonary arterial hypertension and right ventricular failure Role of oxidized lipids in pulmonary arterial hypertension Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury Altered expression of nuclear and cytoplasmic histone H1 in pulmonary artery and pulmonary artery smooth muscle cells in patients with IPAH.Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension PPARγ attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart.Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells.Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation PPAR-γ regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flow Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ.An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH.Unrecognized glucose intolerance is common in pulmonary arterial hypertension Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome.Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation.The Role of PPARgamma in pulmonary vascular disease PPARgamma: a novel molecular target in lung disease.Apoptosis in lung injury and remodeling.The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.Spatial and temporal dynamics of the endothelium.

P2860

Q24338499-D95D6238-E854-4D16-A821-04A64C46D21B Q24642728-6597F9C5-61ED-4C4E-B3AC-295BD692C69A Q24814517-A3FD1892-59E3-4664-B84E-9D6910A67A4B Q26744761-9401F32C-3B12-479B-9FA4-3996491A4CEC Q26821779-7B20B45E-2092-4CDE-9EAC-62680C648E98 Q28078566-D95961A8-037D-4B5C-BBE0-29BE349408C2 Q28593367-7A5718D8-E478-42CC-8417-B3E22412BBDA Q30461346-1287E2C6-E509-41BF-BFAE-65F4DA5243E1 Q33593476-ED4E9B4C-DA26-4CA9-A545-1CA629CD596F Q33692662-A01BD574-703F-42A0-B247-415427F32A31 Q33738569-F24DAF47-CFBC-49D2-99B2-92A366D870B4 Q33831356-3E86487D-B804-4443-A548-6F24FF83D98E Q33863173-507C2DCD-18B6-453C-9E23-BE57DE6CFCBC Q34178976-7B37A223-2830-4917-A3C0-11FD875E7758 Q34212735-C59A3F2F-D914-4AE3-9D88-E96FB52DD242 Q34245617-314A3112-CD0F-4351-AA02-733C9EB01DC1 Q34294854-E0CAA73C-359A-4CD5-A246-611DC8D63EEE Q34409704-D015D85D-5B27-4A36-82CC-7C47BD8E6783 Q34480264-31C19E61-4778-43CE-8FC1-24E844EFE20D Q34589929-9A2412A0-A874-4FA6-A50A-CC9382E90E40 Q34897476-871A339A-F0D6-4640-9E3D-927A6BD8BCC2 Q34973575-536ABA9A-6C2E-4361-BC52-8A0A9A8E290F Q35085796-0B83E894-5AF5-4EDA-96DF-8CC745F27ECC Q35102314-25BD734F-8B9D-4526-A58D-2479041792D7 Q35187029-4CA45BCB-5AE5-4C41-9A53-8890D4DD6821 Q35219809-D8B58A60-09C3-4576-ABEA-3D67994964E1 Q35354138-036D03BE-62A2-441E-A20B-4B8F3C021DE1 Q35601455-A65C8778-2116-479A-8B0B-AE33D23AEA03 Q35601475-5B3DAE9B-115D-43F5-9160-EA0BA95F0D5A Q35711530-DD98DA4B-601A-48EE-A92F-6B9227DD1012 Q35760657-140D2926-7F90-4E49-AE83-4CE5A91B83F0 Q35763145-1AC20A80-39BD-4470-916F-76A612AEEECA Q35794254-1D8D3AD7-8AA6-4DAA-B3A7-52BA6B734E1E Q35805954-035389CB-0442-405C-90B6-58CB6733CDC7 Q35883362-C03F162A-9357-40B2-87B1-E32EEA44D8B4 Q35925357-0A81D51A-F775-4DAA-A71B-20B63CF934E5 Q35954579-1C1BFF18-3150-48FC-8F72-9AA9CFDA7FF0 Q36063833-C96B0B9B-4928-4E7D-9D73-7AE156735EAF Q36093802-3EEF6D83-5D64-46D2-AB3C-6B34E8E7E228 Q36126944-771C34AB-2C00-43D1-8089-6ECD26AD4354

P2860

Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth.

http://www.wikidata.org/entity/Q40652271

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Peroxisome proliferator-activa ...... fects endothelial cell growth.

@en

type

label

Peroxisome proliferator-activa ...... fects endothelial cell growth.

@en

prefLabel

Peroxisome proliferator-activa ...... fects endothelial cell growth.

@en

P1433

Q40652271-7F7FCB9A-B4E2-47BB-BF1C-BE702D2E5F1A

P1476

Q40652271-428384C3-98E9-43A6-9609-30D36FB4B63B

P2093

Q40652271-0853AB4D-FEC0-4FF7-9C5E-5ED674B9E551

Q40652271-155456DC-AC42-46AA-A951-F2AABA4AACA7

Q40652271-2521AFD8-8154-4438-A74A-D08A3FF4BC78

Q40652271-4C5A14B5-382C-4199-B382-0F139F54BB8F

Q40652271-BABAC661-F965-4624-88A0-6804AFD82D81

Q40652271-C6891C14-AC78-4E5A-9800-346C2C376261

Q40652271-D5E0F834-787D-4124-8F54-644470FF2232

Q40652271-DCD19D35-E827-497A-A601-A5ABA082154E

Q40652271-F66AC89D-8A07-4880-908E-20F850068737

Q40652271-FE4D6ED7-2C8C-438B-B1F0-06B18A557B09

P304

Q40652271-42E2D209-8EED-4163-9995-061D1C9DC2E7

P31

Q40652271-D2966E33-329E-422D-A9DA-FED6E75997C6

P356

Q40652271-3460F417-C77F-4594-881E-830646710824

P433

Q40652271-41C58C93-402E-45FB-B64A-EFEE1B90222C

P478

Q40652271-35B84A07-1EA1-4611-AA08-573D4DECF341

P577

Q40652271-D4B6DB22-BAED-4DBC-A25E-27DC8F0A1D74

P698

Q40652271-F690AF84-7D16-4AD5-A27F-0EC1926B1849

P921

Q40652271-76F6C2D9-406A-4BAB-892D-2D29B063BE83

P356

01.RES.0000073585.50092.14

P1433

Circulation Research

P1476

Peroxisome proliferator-activa ...... fects endothelial cell growth.

@en

P2093

Carlyne D Cool

http://www.w3.org/2001/XMLSchema#string

Daniel Chan

http://www.w3.org/2001/XMLSchema#string

Heiko Golpon

http://www.w3.org/2001/XMLSchema#string

Marilee Wick

http://www.w3.org/2001/XMLSchema#string

Mark W Geraci

http://www.w3.org/2001/XMLSchema#string

Norbert F Voelkel

http://www.w3.org/2001/XMLSchema#string

R William Vandivier

http://www.w3.org/2001/XMLSchema#string

Raphael A Nemenoff

http://www.w3.org/2001/XMLSchema#string

Shingo Ameshima

http://www.w3.org/2001/XMLSchema#string

Shyra J Gardai

http://www.w3.org/2001/XMLSchema#string

P304

1162-1169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.0000073585.50092.14

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12714563

http://www.w3.org/2001/XMLSchema#string

P921